Document Detail


Comparison of hemostatic effects by route of H2 receptor antagonist administration following endoscopic mucosal resection in patients with neoplastic gastric lesions.
MedLine Citation:
PMID:  15943856     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: To date, there has not been an in-depth investigation to identify differences in the effects of bleeding prevention among different routes of administration of H2 receptor antagonists to treat gastric ulcers following endoscopic mucosal resection (EMR). AIM: To prospectively compare the frequency of bleeding following EMR between patients treated with intravenous (IV) famotidine and those with oral famotidine. METHODS: Fifty-three patients with neoplastic gastric lesions (33 carcinoma and 20 adenoma) treated by EMR were included. Subjects underwent EMR with circumferential mucosal incision assisted by submucosal injection of sodium hyaluronate (EMRSH), followed by IV or oral (PO) administration of famotidine at a dosage of 40 mg/day for 2 days. Patients with odd ID numbers were assigned to IV therapy (30 cases) while even numbers were given PO therapy (23 cases). Frequencies and endoscopic findings of bleeding during the first 2 days after EMR were examined. RESULTS: Frequency of bleeding within 2 days after EMR was 3 and 4% in IV and PO patients, respectively, showing no significant difference. No significant difference was seen in the endoscopic findings of bleeding and therapy, either, with respective IV and PO findings at 23 and 26%. CONCLUSIONS: No significant difference was observed in frequency of bleeding within 2 days after gastric EMR between IV and oral administrations of famotidine.
Authors:
K Satoh; H Yamamoto; H Kawata; H Osawa; K Hanatsuka; H Kita; K Sunada; T Hirasawa; M Yoshizawa; H Ajibe; Y Satoh; F Sunada; K Sugano
Related Documents :
18629446 - Acute in-vivo evaluation of bleeding with gelfoam plus saline and gelfoam plus human th...
15928966 - Intracranial haemorrhage in a boy with severe haemophilia a and factor viii inhibitor.
11756906 - Randomized trial of normal saline solution injection versus bipolar electrocoagulation ...
9245226 - Successful treatment of acquired hemophilia with oral immunosuppressive therapy.
9074266 - Intratissue laser thermotherapy in treatment of uterine myomata
15178716 - Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thr...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Alimentary pharmacology & therapeutics     Volume:  21 Suppl 2     ISSN:  0269-2813     ISO Abbreviation:  Aliment. Pharmacol. Ther.     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-06-09     Completed Date:  2005-08-15     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8707234     Medline TA:  Aliment Pharmacol Ther     Country:  England    
Other Details:
Languages:  eng     Pagination:  105-10     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology, Jichi Medical School, Kawachi-gun, Tochigi, Japan. kiichi@jichi.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy*,  surgery
Adjuvants, Immunologic / administration & dosage
Administration, Oral
Aged
Endoscopy, Gastrointestinal / adverse effects
Famotidine / administration & dosage*
Female
Gastrointestinal Hemorrhage / etiology,  prevention & control*
Hemostasis, Endoscopic / adverse effects
Histamine H2 Antagonists / administration & dosage*
Humans
Hyaluronic Acid / administration & dosage
Infusions, Intravenous
Intestinal Mucosa / surgery
Male
Middle Aged
Postoperative Hemorrhage / etiology,  prevention & control*
Prospective Studies
Recurrence
Stomach Neoplasms / drug therapy*,  surgery
Chemical
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Histamine H2 Antagonists; 76824-35-6/Famotidine; 9004-61-9/Hyaluronic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of long-term half-dose famotidine therapy on corpus gastritis in peptic ulcer disease.
Next Document:  A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding aft...